SUPERNUS PHARMACEUTICALS, INC. Research and Development Expense
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Research and Development Expense of $29.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-06-30 was $29.46M, a 33.23% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-03-31 was $39.44M, a 46.46% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-12-31 was $27.83M, a 2.86% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-09-30 was $29.37M, a 1.14% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for fiscal 2025 was $106.23M, a 2.35% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for fiscal 2024 was $108.80M, a 18.78% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $91.59M, a 22.86% increase from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $74.55M, a 17.59% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.46M 10-Q · filed 2026-08-03 | $68.90M 10-Q · filed 2026-08-03 | $96.73M derived: sum of 3 quarters · filed 2026-08-03 | $126.09M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $39.44M 10-Q · filed 2026-05-05 | $67.27M derived: sum of 2 quarters · filed 2026-05-05 | $96.63M derived: sum of 3 quarters · filed 2026-05-05 | $118.75M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $27.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $57.19M derived: sum of 2 quarters · filed 2026-03-02 | $79.31M derived: sum of 3 quarters · filed 2026-08-03 | $106.23M 10-K · filed 2026-03-02 |
| 2025-09-30 | $29.37M 10-Q · filed 2025-11-06 | $51.48M derived: sum of 2 quarters · filed 2026-08-03 | $78.41M 10-Q · filed 2025-11-06 | $107.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $22.11M 10-Q · filed 2026-08-03 | $49.04M 10-Q · filed 2026-08-03 | $77.69M derived: sum of 3 quarters · filed 2026-08-03 | $106.72M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $26.93M 10-Q · filed 2026-05-05 | $55.57M derived: sum of 2 quarters · filed 2026-05-05 | $84.61M derived: sum of 3 quarters · filed 2026-05-05 | $110.79M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $28.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $57.68M derived: sum of 2 quarters · filed 2026-03-02 | $83.87M derived: sum of 3 quarters · filed 2026-03-02 | $108.80M 10-K · filed 2026-03-02 |
| 2024-09-30 | $29.04M 10-Q · filed 2025-11-06 | $55.22M derived: sum of 2 quarters · filed 2025-11-06 | $80.15M 10-Q · filed 2025-11-06 | $103.50M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $26.18M 10-Q · filed 2025-08-05 | $51.11M 10-Q · filed 2025-08-05 | $74.46M derived: sum of 3 quarters · filed 2026-03-02 | $97.11M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $24.93M 10-Q · filed 2025-05-06 | $48.28M derived: sum of 2 quarters · filed 2026-03-02 | $70.93M derived: sum of 3 quarters · filed 2026-03-02 | $95.31M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $23.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $46.00M derived: sum of 2 quarters · filed 2026-03-02 | $70.38M derived: sum of 3 quarters · filed 2026-03-02 | $91.59M 10-K · filed 2026-03-02 |
| 2023-09-30 | $22.66M 10-Q · filed 2024-11-04 | $47.03M derived: sum of 2 quarters · filed 2024-11-04 | $68.25M 10-Q · filed 2024-11-04 | $86.02M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $24.38M 10-Q · filed 2024-08-06 | $45.59M 10-Q · filed 2024-08-06 | $63.37M derived: sum of 3 quarters · filed 2025-02-25 | $82.92M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $21.21M 10-Q · filed 2024-05-08 | $38.99M derived: sum of 2 quarters · filed 2025-02-25 | $58.54M derived: sum of 3 quarters · filed 2025-02-25 | $74.92M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $17.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $37.33M derived: sum of 2 quarters · filed 2025-02-25 | $53.71M derived: sum of 3 quarters · filed 2025-02-25 | $74.55M 10-K · filed 2025-02-25 |
| 2022-09-30 | $19.55M 10-Q · filed 2023-11-08 | $35.94M derived: sum of 2 quarters · filed 2023-11-08 | $56.78M 10-Q · filed 2023-11-08 | $77.86M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $16.39M 10-Q · filed 2023-08-08 | $37.22M 10-Q · filed 2023-08-08 | $58.30M derived: sum of 3 quarters · filed 2023-08-08 | $77.96M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $20.84M 10-Q · filed 2023-05-09 | $41.92M derived: sum of 2 quarters · filed 2023-05-09 | $61.57M derived: sum of 3 quarters · filed 2023-05-09 | $77.03M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $21.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $40.73M derived: sum of 2 quarters · filed 2023-03-09 | $56.19M derived: sum of 3 quarters · filed 2023-03-09 | $90.47M 10-K · filed 2023-03-09 |
| 2021-09-30 | $19.65M 10-Q · filed 2022-11-09 | $35.11M derived: sum of 2 quarters · filed 2022-11-09 | $69.39M 10-Q · filed 2022-11-09 | $87.33M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | $15.46M 10-Q · filed 2022-08-08 | $49.73M 10-Q · filed 2022-08-08 | $67.67M derived: sum of 3 quarters · filed 2023-03-09 | $84.51M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | $34.28M 10-Q · filed 2022-05-12 | $52.22M derived: sum of 2 quarters · filed 2023-03-09 | $69.06M derived: sum of 3 quarters · filed 2023-03-09 | $91.30M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $17.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $34.78M derived: sum of 2 quarters · filed 2023-03-09 | $57.02M derived: sum of 3 quarters · filed 2023-03-09 | $75.96M 10-K · filed 2023-03-09 |
| 2020-09-30 | $16.84M 10-Q · filed 2021-11-05 | $39.09M derived: sum of 2 quarters · filed 2021-11-05 | $58.02M 10-Q · filed 2021-11-05 | $77.81M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-06-30 | $22.25M 10-Q · filed 2021-08-06 | $41.18M 10-Q · filed 2021-08-06 | $60.98M derived: sum of 3 quarters · filed 2022-04-13 | $77.92M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-03-31 | $18.94M 10-Q · filed 2021-05-07 | $38.73M derived: sum of 2 quarters · filed 2022-04-13 | $55.67M derived: sum of 3 quarters · filed 2022-04-13 | $72.64M derived: sum of 4 quarters · filed 2022-04-13 |
| 2019-12-31 | $19.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $36.73M derived: sum of 2 quarters · filed 2022-04-13 | $53.70M derived: sum of 3 quarters · filed 2022-04-13 | $69.10M 10-K · filed 2022-04-13 |
| 2019-09-30 | $16.94M 10-Q · filed 2020-11-06 | $33.91M derived: sum of 2 quarters · filed 2020-11-06 | $49.31M 10-Q · filed 2020-11-06 | $79.15M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $16.97M 10-Q · filed 2020-08-17 | $32.36M 10-Q · filed 2020-08-17 | $62.20M derived: sum of 3 quarters · filed 2021-03-08 | $82.63M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $15.39M 10-Q · filed 2020-05-15 | $45.23M derived: sum of 2 quarters · filed 2021-03-08 | $65.66M derived: sum of 3 quarters · filed 2021-03-08 | $85.69M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $29.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $50.26M derived: sum of 2 quarters · filed 2021-03-08 | $70.30M derived: sum of 3 quarters · filed 2021-03-08 | $89.21M 10-K · filed 2021-03-08 |
| 2018-09-30 | $20.42M 10-Q · filed 2019-11-08 | $40.46M derived: sum of 2 quarters · filed 2019-11-08 | $59.37M 10-Q · filed 2019-11-08 | $75.54M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $20.04M 10-Q · filed 2019-08-09 | $38.95M 10-Q · filed 2019-08-09 | $55.12M derived: sum of 3 quarters · filed 2020-02-28 | $68.10M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $18.91M 10-Q · filed 2019-05-10 | $35.08M derived: sum of 2 quarters · filed 2020-02-28 | $48.06M derived: sum of 3 quarters · filed 2020-02-28 | $58.88M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $16.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $29.15M derived: sum of 2 quarters · filed 2020-02-28 | $39.98M derived: sum of 3 quarters · filed 2020-02-28 | $49.58M 10-K · filed 2020-02-28 |
| 2017-09-30 | $12.98M 10-Q · filed 2018-11-09 | $23.80M derived: sum of 2 quarters · filed 2018-11-09 | $33.41M 10-Q · filed 2018-11-09 | $46.66M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $10.82M 10-Q · filed 2018-08-09 | $20.43M 10-Q · filed 2018-08-09 | $33.68M derived: sum of 3 quarters · filed 2019-03-01 | $41.54M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $9.60M 10-Q · filed 2018-05-10 | $22.85M derived: sum of 2 quarters · filed 2019-03-01 | $30.72M derived: sum of 3 quarters · filed 2019-03-01 | $41.83M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $13.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $21.12M derived: sum of 2 quarters · filed 2019-03-01 | $32.23M derived: sum of 3 quarters · filed 2019-03-01 | $42.79M 10-K · filed 2019-03-01 |
| 2016-09-30 | $7.87M 10-Q · filed 2017-11-09 | $18.98M derived: sum of 2 quarters · filed 2017-11-09 | $29.54M 10-Q · filed 2017-11-09 | $38.98M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $11.11M 10-Q · filed 2017-08-03 | $21.67M 10-Q · filed 2017-08-03 | $31.12M derived: sum of 3 quarters · filed 2018-03-01 | $40.24M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $10.56M 10-Q · filed 2017-05-09 | $20.01M derived: sum of 2 quarters · filed 2018-03-01 | $29.14M derived: sum of 3 quarters · filed 2018-03-01 | $36.01M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $9.45M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $18.57M derived: sum of 2 quarters · filed 2018-03-01 | $25.45M derived: sum of 3 quarters · filed 2018-03-01 | $29.14M 10-K · filed 2018-03-01 |
| 2015-09-30 | $9.13M 10-Q/A · filed 2017-01-20 | $16.01M derived: sum of 2 quarters · filed 2017-01-23 | $19.69M 10-Q/A · filed 2017-01-20 | $25.46M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $6.88M 10-Q/A · filed 2017-01-23 | $10.56M 10-Q/A · filed 2017-01-23 | $16.33M derived: sum of 3 quarters · filed 2017-03-16 | $20.99M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $3.68M 10-Q/A · filed 2017-01-20 | $9.45M derived: sum of 2 quarters · filed 2017-03-16 | $14.11M derived: sum of 3 quarters · filed 2017-03-16 | $18.79M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $5.77M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $10.43M derived: sum of 2 quarters · filed 2017-03-16 | $15.10M derived: sum of 3 quarters · filed 2017-03-16 | $19.59M 10-K · filed 2017-03-16 |
| 2014-09-30 | $4.66M 10-Q/A · filed 2017-01-20 | $9.33M derived: sum of 2 quarters · filed 2017-01-20 | $13.82M 10-Q/A · filed 2017-01-20 | $19.22M derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-06-30 | $4.68M 10-Q · filed 2015-08-07 | $9.16M 10-Q · filed 2015-08-07 | $14.56M derived: sum of 3 quarters · filed 2017-01-20 | $18.34M derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-03-31 | $4.48M 10-Q · filed 2015-05-06 | $9.88M derived: sum of 2 quarters · filed 2017-01-20 | $13.66M derived: sum of 3 quarters · filed 2017-01-20 | $17.20M derived: sum of 4 quarters · filed 2017-01-20 |
| 2013-12-31 | $5.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | $9.18M derived: sum of 2 quarters · filed 2017-01-20 | $12.72M derived: sum of 3 quarters · filed 2017-01-20 | $17.25M 10-K/A · filed 2017-01-20 |
| 2013-09-30 | $3.78M 10-Q · filed 2014-11-12 | $7.32M derived: sum of 2 quarters · filed 2014-11-12 | $11.84M 10-Q · filed 2014-11-12 | $16.99M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $3.54M 10-Q · filed 2014-08-12 | $8.06M 10-Q · filed 2014-08-12 | $13.21M derived: sum of 3 quarters · filed 2015-03-12 | $21.52M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $4.52M 10-Q · filed 2014-05-13 | $9.67M derived: sum of 2 quarters · filed 2015-03-12 | $17.98M derived: sum of 3 quarters · filed 2015-03-12 | $22.68M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $13.46M derived: sum of 2 quarters · filed 2015-03-12 | $18.16M derived: sum of 3 quarters · filed 2015-03-12 | $23.52M 10-K · filed 2015-03-12 |
| 2012-09-30 | $8.31M 10-Q · filed 2013-11-13 | $13.01M derived: sum of 2 quarters · filed 2013-11-13 | $18.37M 10-Q · filed 2013-11-13 | $25.87M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $4.70M 10-Q · filed 2013-08-14 | $10.06M 10-Q · filed 2013-08-14 | $17.56M derived: sum of 3 quarters · filed 2014-03-21 | $25.99M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $5.36M 10-Q · filed 2013-05-15 | $12.86M derived: sum of 2 quarters · filed 2014-03-21 | $21.28M derived: sum of 3 quarters · filed 2014-03-21 | $28.54M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $15.93M derived: sum of 2 quarters · filed 2014-03-21 | $23.18M derived: sum of 3 quarters · filed 2014-03-21 | $30.63M 10-K · filed 2014-03-21 |
| 2011-09-30 | $8.43M 10-Q · filed 2012-11-02 | $15.68M derived: sum of 2 quarters · filed 2012-11-02 | $23.13M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $7.25M 10-Q · filed 2012-08-13 | $14.70M 10-Q · filed 2012-08-13 | ||
| 2011-03-31 | $7.45M 10-Q · filed 2012-06-08 | |||
| 2010-12-31 | $35.15M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |